ACAshu Chaudhary

Ashu Chaudhary

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ashu Chaudhary has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Green Synthesis, Coordination Properties and Emerging Applications of Schiff Base Metal Complexes: Recent Advances and Future Perspectives

    by Pranjal Sharma, Ashu Chaudhary

    Schiff base ligands are essential for a number of chemical reactions because of their adaptable coordination skills and adjustable characteristics. This paper examines the latest developments in the synthesis of Schiff base ligands, comparing conventional condensation methods with green synthetic approaches such as natural acid catalysis, aqueous media synthesis, mechanochemistry, microwave-assisted synthesis, and ultrasound irradiation. Their coordination chemistry is examined in terms of donor modes, coordination geometries, and spectroscopic/crystallographic characterization, with attention to how ligand structure and metal-ion selection govern structure–activity relationships, supported by recent computational and spectroscopic advances in understanding metal–ligand interactions. Biological activities, including antibacterial, antifungal, anticancer, antioxidant, and anti-inflammatory effects, and their mechanisms are discussed alongside applications in catalysis, chemical sensing, corrosion inhibition, metal–organic frameworks, and environmental remediation. Current limitations in scalability, reproducibility, and clinical translation are outlined, together with future directions emphasizing sustainable synthesis, advanced characterization, and rational ligand design.


  • Open Access

    Phytochemical-mediated green synthesis, mechanistic insights integrated with biological evaluation, density functional theory calculations and molecular docking studies of copper oxide nanoparticles

    by Annu Devi, Madhu, Ashu Chaudhary

    Copper oxide nanoparticles have attracted considerable attention due to their notable roles in catalysis, sensing technologies, and biomedical research. In the present work, copper oxide nanoparticles (CuONPs) were prepared through a green synthetic strategy employing aqueous extracts of Azadirachta indica and Aloe vera as natural reducing and capping agents. This plant-assisted approach offers an eco-friendly, economical, and sustainable substitute for traditional chemical synthesis routes that often involve hazardous reagents. Comprehensive characterization techniques were used to confirm nanoparticle formation and evaluate their properties. FTIR analysis showed a distinct Cu–O stretching band near 542 cm− 1, verifying the formation of copper oxide. XRD patterns confirmed the crystalline nature of the particles, with an average crystallite size of about 26.3 nm. Microscopic studies (SEM and TEM) revealed nanoscale particles mainly distributed between 20 and 50 nm with an average particle size of approximately 34 nm. Elemental analysis by EDX verified copper and oxygen as the dominant elements, with weight percentages of 77.51% and 22.49%, respectively, confirming the successful formation of CuONPs, while Zeta potential measurements revealed a zeta potential value of 4.93 mV with a polydispersity index (PDI) of 0.454, indicating moderate colloidal stability and a relatively broad particle size distribution of the synthesized CuONPs. Biological investigations demonstrated strong activity, with over 70% inhibition observed in antioxidant and anti-inflammatory assays at higher concentrations. Additionally, CuONPs exhibited highest antimicrobial activity against B. subtilis with zone of inhibition 23 ± 0.6 mm. Theoretical studies using density functional theory and molecular docking supported the experimental findings. Collectively, the study highlights the promising biomedical potential of green-synthesized CuONPs.


  • A Novel Approach: Synthesis of Biologically Potent Copper Oxide Nanoparticles Derived From Expired Medicine

    by Madhu, Subhash, Annu Devi, Nistha Ghalayan, Neeraj Kumar Agarwal, Ashu Chaudhary

    The present work introduces a sustainable and economical approach for recycling pharmaceutical waste, specifically expired paracetamol and Disprin, into biologically active copper oxide nanoparticles (CuONPs). The synthesized nanomaterials were examined using FT‐IR, XRD, SEM, TEM, and EDS techniques. FT‐IR spectra confirmed the presence of Cu–O vibrations at 520 and 540 cm − 1 , while XRD analysis revealed a monoclinic crystalline phase with high structural stability. EDS analysis verified elemental purity, showing prominent Cu peaks and weight percentages of 73.42% for P‐CuONPs and 76.59% for D‐CuONPs. DLS measurements indicated moderately polydisperse behavior with Z‐average hydrodynamic diameters ranging from 1589.1 to 3786 nm, while negative zeta potential values (−13.3 to −21.2 mV) suggested moderate colloidal stability. Morphological investigations by SEM and TEM showed spherical, uniformly distributed particles with an average size of 20–50 nm. Theoretical calculations and molecular dynamics simulations supported the experimental findings. P‐CuONPs effectively inhibited S. aureus 17(±0.3) mm and E. coli 20(±0.4) mm, whereas D‐CuONPs showed activity only against E. coli 15(±0.3) mm. Neither type exhibited antifungal effects against C. albicans . Antioxidant assays confirmed strong free radical scavenging properties, with P‐CuONPs performing most efficiently with an IC 50 value of 45.58 µg/mL. Anti‐inflammatory analysis revealed concentration‐dependent inhibition, comparable to sodium diclofenac, with P‐CuONPs showing superior activity compared to D‐CuONPs. Overall, this study highlights an eco‐friendly strategy for repurposing expired drugs into CuONPs with significant antimicrobial, antioxidant, and anti‐inflammatory potential, offering promising applications in biomedical research.


  • Open Access

    Novel amide-based macrocyclic Co( ii ) complexes: correlating structural, computational, and biological properties through DFT and docking

    by Manish Kumar, Annu Devi, Ashu Chaudhary

    A series of Co(II) complexes incorporating functionalized macrocyclic scaffolds, designated as [Co(N4O4MacL1)Cl2]–[Co(N4O4MacL3)Cl2], were synthesized using three structurally related macrocyclic ligands (N4O4MacL1–N4O4MacL3), each featuring an amide-based tetradentate donor framework. The complexes were comprehensively characterized by elemental analysis, FTIR spectroscopy, magnetic susceptibility measurements, UV-visible spectroscopy, 1H and 13C NMR spectroscopy, and powder X-ray diffraction. Spectroscopic and analytical findings confirm that the ligands act as monoanionic tetradentate donors, coordinating through nitrogen and oxygen donor sites. The magnetic and electronic spectral data support an octahedral coordination geometry around the Co(II) center in all complexes. Thermal stability and kinetic parameters were assessed through thermogravimetric analysis, employing the Coats-Redfern and Flynn-Wall-Ozawa (FWO) models to determine activation energies and thermodynamic parameters. Moreover, density functional theory (DFT) calculations provided insights into optimized geometries, bond parameters, and frontier molecular orbital characteristics, which corroborate the experimental observations. The biological activities of the ligands and their Co(II) complexes were evaluated through in vitro antimicrobial assays against fungal strains A. niger and C. albicans, and bacterial strains B. subtilis, S. aureus, E. coli, and S. typhi. Additionally, antioxidant activity assessed by the DPPH free-radical scavenging assay revealed that [Co(N4O4MacL3)Cl2] demonstrated the highest radical-quenching efficiency. Among the complexes studied, [Co(N4O4MacL2)Cl2] displayed the most promising antimicrobial activity with minimal cytotoxic effects. Molecular docking studies further validated the biological results, indicating favourable interactions of the complexes with relevant biomolecular targets. Overall, these findings highlight the therapeutic potential of amide-containing macrocyclic ligands and their cobalt(II) complexes as promising candidates for antimicrobial applications, selective cytotoxic behaviour, and effective antioxidant activity.


  • Synthesis, Structural Elucidation, Density Functional Theory Calculations, In Vitro Antimicrobial, Anti‐Inflammatory and Anticancer Activities of Novel Zn (II)‐Group Fourteen Heterobimetallic Complexes Derived From Schiff Base Ligand

    by Mamta, Ashu Chaudhary

    In the present work, new heterobimetallic complexes with the general formula [Zn(C16H32N8)M2(R)4Cl2], where M = Sn (IV) and Si (IV) and R = ‐CH3 and ‐C6H5, were synthesized by reacting the methanolic solution of the monometallic complex [Zn(C16H36N8)Cl2] with group 14 organometallic dichloride [(CH3)2SnCl2/(C6H5)2SnCl2/(CH3)2SiCl2/(C6H5)2SiCl2]. The structures of the synthesized complexes were determined using several spectrometric techniques, including FT‐IR, 1H NMR, 13C NMR, 119Sn NMR, 29Si NMR, ESI‐MS, PXRD, and molar conductivity measurements. Density functional theory (DFT) calculations were carried out to investigate the quantum chemical characteristics of the newly synthesized Zn (II) complexes. The antimicrobial potential of the monometallic and heterobimetallic complexes was evaluated against two Gram‐positive bacteria (Bacillus subtilis and Bacillus cereus), two Gram‐negative bacteria (Xanthomonas campestris and Pseudomonas aeruginosa), and two fungal strains (Aspergillus flavus and Fusarium oxysporum) by the agar well diffusion method, with heterobimetallic complex [Zn(C16H32N8)Sn2(C6H5)4Cl2] as the most potent complex against microbes. The complex [Zn(C16H32N8)Sn2(C6H5)4Cl2] exhibited significant potential in inhibiting inflammation, demonstrating an IC50 value of 9.75 μg/mL, which closely rivals that of the standard drug sodium diclofenac (IC50 = 4.59 μg/mL). Furthermore, all the synthesized compounds were assessed for their anticancer potential against three cancer cell lines (HCT‐116, MCF‐7, and HeLa) by the MTT assay. The results indicated that the complex [Zn(C16H32N8)Sn2(C6H5)4Cl2] exhibited the most pronounced cytotoxic effects, with values of 4.25 ± 0.15 μM, 4.90 ± 0.18 μM, and 5.20 ± 0.24 μM observed for HCT‐116, MCF‐7, and HeLa cancer cell lines, respectively.

  • Novel tetraaza macrocyclic Schiff base complexes of bivalent zinc: microwave-assisted green synthesis, spectroscopic characterization, density functional theory calculations, molecular docking studies, in vitro antimicrobial and anticancer activities

    by Mamta, Ashu Chaudhary

    In the present manuscript, novel macrocyclic Schiff base complexes [Zn(N4MacL1)Cl2–Zn(N4MacL3)Cl2] were synthesized by the reaction of ZnCl2 and macrocyclic ligands (N4MacL1–N4MacL3) derived from diketone and diamines under microwave irradiation method and conventional method. The structures of the obtained complexes were identified by various spectrometric methods such as Fourier transformation infra-red (FT-IR), nuclear magnetic resonance (NMR), high-resolution mass spectrometry (HR-MS), powder X-ray diffraction, molar conductivity, and UV–vis. The structures of the synthesized compounds were optimized by using the def2–TZV/J and def2–SVP/J Coulomb fitting basis sets at B3LYP level in density functional theory (DFT) calculations. The macrocyclic Schiff base complexes exhibited higher activities against Gram-positive bacteria (Staphylococcus aureus and Bacillus cereus), Gram-negative bacteria (Escherichia coli and Xanthomonas campestris), and fungal strains (Fusarium oxysporum and Candida albicans) in comparison to macrocyclic Schiff base ligands. Furthermore, the newly synthesized macrocyclic compounds were assessed for their anticancer activity against three cell lines: A549 (human alveolar adenocarcinoma epithelial cell line), HT-29 (human colorectal adenocarcinoma cell line), and MCF-7 (human breast adenocarcinoma cell line) using the MTT assay. The obtained results showed that the macrocyclic complex [Zn(N4MacL3)Cl2] displayed the highest cytotoxic activity (2.23 ± 0.25 µM, 6.53 ± 0.28 µM, and 7.40 ± 0.45 µM for A549, HT-29, and MCF-7 cancer cell lines, respectively). Additionally, molecular docking investigations were conducted to elucidate potential molecular interactions between the synthesized macrocyclic compounds and target proteins. The results revealed a consistent agreement between the docking calculations and the experimental data. Graphical abstract